Alan C. Mendelson's most recent trade in Coherus Biosciences Inc was a trade of 20,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on May 21, 2021.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Coherus Biosciences Inc | Alan C. Mendelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2021 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
| Coherus Biosciences Inc | Alan C. Mendelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2021 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) |